Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.67 is 29% below its 3-year average of -2.07, near the low end of its 3-year range (-2.67–-1.75).
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-07-31): -0.75.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.67
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-2.07
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-28.78%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Kestra Medical Technologies, Ltd.
Market Cap
$1.68B
Earnings Per Share (EPS)
-2.67
TTM Avg
N/A
3Y Avg
-2.07
5Y Avg
N/A
Market Cap
$1.66B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.71B
Earnings Per Share (EPS)
0.19
TTM Avg
-0.34
3Y Avg
-0.57
5Y Avg
-0.59
Market Cap
$1.65B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.73B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$1.75B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.33
3Y Avg
-3.33
5Y Avg
-3.33
Market Cap
$1.81B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$1.55B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.53B
Earnings Per Share (EPS)
4.10
TTM Avg
2.19
3Y Avg
2.59
5Y Avg
2.64
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.68B | -2.67 | N/A | -2.07 | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -0.72 | -1.04 | -1.27 | -1.30 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.71B | 0.19 | -0.34 | -0.57 | -0.59 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 4.63 | 1.23 | 0.09 | -0.82 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -2.74 | -3.74 | -3.13 | -1.84 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.75B | N/A | -3.33 | -3.33 | -3.33 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.81B | -3.36 | -4.53 | -5.16 | -4.47 |
| Certara, Inc. (CERT)vs › | $1.55B | -0.44 | -0.04 | -0.09 | -0.12 |
| Innoviva, Inc. (INVA)vs › | $1.53B | 4.10 | 2.19 | 2.59 | 2.64 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 2.85 | 2.25 | 1.70 | 1.52 |
Trailing EPS (TTM)
$-2.67
Forward EPS (Est.)
$-2.45
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-04-30 | -2.43 |
| 2024-04-30 | -2.04 |
| 2023-04-30 | -1.75 |
